Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2‑Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators

Cannabinoid 1 receptor (CB1R) allosteric ligands hold a far-reaching therapeutic promise. We report the application of fluoro- and nitrogen-walk approaches to enhance the drug-like properties of GAT211, a prototype CB1R allosteric agonist-positive allosteric modulator (ago-PAM). Several analogs exhi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2020-01, Vol.63 (2), p.542-568
Main Authors: Garai, Sumanta, Kulkarni, Pushkar M, Schaffer, Peter C, Leo, Luciana M, Brandt, Asher L, Zagzoog, Ayat, Black, Tallan, Lin, Xiaoyan, Hurst, Dow P, Janero, David R, Abood, Mary E, Zimmowitch, Anaelle, Straiker, Alex, Pertwee, Roger G, Kelly, Melanie, Szczesniak, Anna-Maria, Denovan-Wright, Eileen M, Mackie, Ken, Hohmann, Andrea G, Reggio, Patricia H, Laprairie, Robert B, Thakur, Ganesh A
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cannabinoid 1 receptor (CB1R) allosteric ligands hold a far-reaching therapeutic promise. We report the application of fluoro- and nitrogen-walk approaches to enhance the drug-like properties of GAT211, a prototype CB1R allosteric agonist-positive allosteric modulator (ago-PAM). Several analogs exhibited improved functional potency (cAMP, β-arrestin 2), metabolic stability, and aqueous solubility. Two key analogs, GAT591 (6r) and GAT593 (6s), exhibited augmented allosteric-agonist and PAM activities in neuronal cultures, improved metabolic stability, and enhanced orthosteric agonist binding (CP55,940). Both analogs also exhibited good analgesic potency in the CFA inflammatory-pain model with longer duration of action over GAT211 while being devoid of adverse cannabimimetic effects. Another analog, GAT592 (9j), exhibited moderate ago-PAM potency and improved aqueous solubility with therapeutic reduction of intraocular pressure in murine glaucoma models. The SAR findings and the enhanced allosteric activity in this class of allosteric modulators were accounted for in our recently developed computational model for CB1R allosteric activation and positive allosteric modulation.
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.9b01142